Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare ConferenceGlobeNewsWire • 10/13/26
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare ConferenceGlobeNewsWire • 09/01/26
Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PRNewsWire • 08/25/26
Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/10/26
Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease PortfolioGlobeNewsWire • 07/15/26
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/28/26
Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/12/26
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial ResultsGlobeNewsWire • 05/11/26
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing EfficiencyGlobeNewsWire • 04/16/26
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/05/26
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial ResultsGlobeNewsWire • 03/05/26
Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/04/26
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare ConferenceGlobeNewsWire • 02/23/26
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate OutlookGlobeNewsWire • 01/12/26
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature ConferenceGlobeNewsWire • 12/01/25
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership UpdatesGlobeNewsWire • 11/11/25
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical DevelopmentGlobeNewsWire • 11/11/25
Metagenomi Reports Business Updates and Second Quarter 2025 Financial ResultsGlobeNewsWire • 08/12/25